Clinical Trials · NCT02823691
The MetNET-2 Trial
- Phase
- EARLY_Phase 1
- Recruitment status
- Unknown
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Enrollment
- 20
- Start date
- Apr 2016
- Locations
- 1 site, Italy
- Primary endpoint
- incidence of SAEs and AEs